Drug name - Baqsimi

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6938798 ELI LILLY AND CO Fluid or powdery product dispensing device
Jan, 2022

(11 months ago)

US10213487 ELI LILLY AND CO Nasal powder formulation for treatment of hypoglycemia
Feb, 2036

(13 years from now)

US10894133 ELI LILLY AND CO Device for dispensing a fluid product
Jan, 2038

(15 years from now)

US10765602 ELI LILLY AND CO Medication delivery systems and methods
Sep, 2039

(16 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Jul 24, 2022

Drugs and Companies using GLUCAGON ingredient

Market Authorisation Date: 24 July, 2019

Treatment: Treatment of severe hypoglycemia in patients with diabetes

Dosage: POWDER;NASAL

More Information on Dosage
Strength Dosage Availability
3MG POWDER;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in